Literature DB >> 27216882

Evidence of pathogenicity of a mutation in 3' untranslated region causing mild haemophilia A.

B Pezeshkpoor1,2, A-C Berkemeier1,2, K J Czogalla1,2, J Oldenburg1,2, O El-Maarri1,3.   

Abstract

INTRODUCTION: Despite the high mutation detection rate, in a small group of haemophilia A patients, using current screening methods, no causal mutation in F8 can be detected. In such cases, the causal mutation might be in the non-coding sequences of F8. AIM: Rarely, mutations in non-coding sequences reveal a pivotal role. Here, we analysed a mild haemophilia A patient harbouring a mutation in the 3' untranslated region (UTR) of F8 and elucidated the molecular mechanism leading to haemophilia phenotype.
METHODS: To find the causal mutation, the complete F8 genomic region was analysed by next generation sequencing. The effect of the identified alteration on F8 expression was evaluated in silico and analysed for the splicing effect at mRNA level. Moreover, in vitro studies using a luciferase reporter system were performed to functionally analyse the mutation.
RESULTS: We identified an alteration in the 3' UTR (c.*56G>T) as the only change in F8 gene. Pedigree analysis showed a segregation pattern for three affected members for the presumptive mutation. Moreover, the variant was predicted in silico to create a new donor splice site, which was also detected at mRNA level, resulting in a 159 bp deletion in 3' UTR of F8. Finally, the variant showed reduced expression of the gene reporter firefly luciferase in cell line expression analysis.
CONCLUSION: Our results advocate the patient specific c.*56G>T base change in the 3' UTR to be a disease-associated mutation leading to alternative splicing explaining the mild haemophilia A phenotype.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  3′ UTR; alternative splicing; haemophilia A; high-throughput DNA sequencing; mRNA

Mesh:

Substances:

Year:  2016        PMID: 27216882     DOI: 10.1111/hae.12923

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

Review 1.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

2.  An intronic mutation c.6430-3C>G in the F8 gene causes splicing efficiency and premature termination in hemophilia A.

Authors:  Zunjing Xia; Jie Lin; Lingping Lu; Chol Kim; Ping Yu; Ming Qi
Journal:  Blood Coagul Fibrinolysis       Date:  2018-06       Impact factor: 1.276

Review 3.  Role of microRNAs in Hemophilia and Thrombosis in Humans.

Authors:  Katarzyna I Jankowska; Zuben E Sauna; Chintamani D Atreya
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

4.  Functionally Significant Features in the 5' Untranslated Region of the ABCA1 Gene and Their Comparison in Vertebrates.

Authors:  Pavel Dvorak; Sarah Leupen; Pavel Soucek
Journal:  Cells       Date:  2019-06-21       Impact factor: 6.600

5.  Hsa-miR-5581-3p and Hsa-miR-542-3p Target the F8 Gene in Hemophilia A without F8 Mutations.

Authors:  Feiying Meng
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.